Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference91 articles.
1. Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations;Hoos;Nat Rev Drug Discov.,2016
2. An immunogenic personal neoantigen vaccine for patients with melanoma;Ott;Nature,2017
3. Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer;Mitchison;J Exp Med.,1955
4. Chimeric T cell receptor-immunoglobulin molecules: function and applications;Hedrick;Int Rev Immunol,1993
5. Tragedy, perseverance, and chance - the story of CAR-T therapy;Rosenbaum;N Engl J Med.,2017
Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ecological and evolutionary dynamics to design and improve ovarian cancer treatment;Clinical and Translational Medicine;2024-08-29
2. The potential of γδ CAR and TRuC T cells: An unearthed treasure;European Journal of Immunology;2024-08-27
3. Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review;Targeted Oncology;2024-06-19
4. High-multiplex single-cell imaging analysis reveals tumor immune contexture associated with clinical outcomes after CAR T cell therapy;Molecular Therapy;2024-05
5. Prospects and challenges of CAR-T in the treatment of ovarian cancer;International Immunopharmacology;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3